Intuitive Surgical Form 144: 5,600 shares slated for July 2025 sale

Rhea-AI Filing Summary

Intuitive Surgical, Inc. (ISRG) – Form 144 filing: an unidentified insider has notified the SEC of a planned sale of 5,600 common shares through broker Charles Schwab. The shares were acquired via stock-option exercise on 12-03-2018. Proposed sale date is 28-Jul-2025.

The filing lists an aggregate market value of US$2.77 million, implying a price of roughly US$495 per share. Relative to the company’s 358.48 million shares outstanding, the disposition represents only about 0.0016 %, so it is immaterial to the public float. No prior sales were reported for the past three months and no Rule 10b5-1 trading plan date is supplied.

Form 144 indicates intent rather than completion; actual execution will depend on market conditions and the insider’s discretion. While insider selling can sometimes be viewed cautiously by investors, the small size versus total shares and lack of accompanying negative disclosures suggest limited market impact.

Positive

• None.

Negative

• Insider intends to sell 5,600 shares valued at US$2.77 M, which could be interpreted as a mild negative signal despite its immaterial size.

Insights

Securities Analyst

TL;DR: Minor insider sale (5,600 shares, US$2.8 M); negligible dilution; sentiment mildly negative but low impact.

The filing signals that an insider plans to liquidate stock worth about US$2.8 million. With only 0.002 % of outstanding shares involved, the transaction is too small to affect liquidity, ownership concentration, or earnings per share. It follows an option exercise dated 2018, so the seller is likely harvesting gains rather than reacting to recent fundamentals. No pattern of continuous selling is disclosed. Given ISRG’s US$130 B+ market cap, I view the action as routine portfolio management rather than a warning signal. Market impact: not impactful.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	5600	2773344.00	358476506	07/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	12/03/2018	STOCK OPTION EXERCISE	ISSUER			5600	12/03/2018	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Intuitive Surgical (ISRG) shares are being registered for sale?

The Form 144 covers 5,600 common shares.

What is the estimated dollar value of the planned sale?

The aggregate market value reported is approximately US$2.77 million.

When is the insider planning to sell the shares?

The approximate sale date listed is July 28, 2025.

What percentage of ISRG’s shares outstanding does this represent?

About 0.0016 % of the company’s 358.48 million outstanding shares.

Were any other shares sold by this insider during the past three months?

No; the filing states “Nothing to Report” for prior three-month sales.

How were the shares originally acquired?

They were obtained via a stock-option exercise on 12-03-2018.